Human Epidemiology of Newly Identified Arboviruses

NCT04954352 | Unknown

• 1 other identifier: RECHMPL21_0297
• Study Type: observational
• Target: 400
• Locations: 1 country
• Sites: 1

Brief Summary

A local network is being set up to study the impact of arboviruses in our region. It is committed to a one-health approach, in particular with research without a priori for new viruses hosted among vectors and wildlife. The candidates identified by high throughput sequencing approaches will serve as a basis for the development of serological and molecular tools for their detections. These tools will be used to assess the possible circulation of these new viruses in humans in biological collections created within the framework of this project Arbodocc .

Conditions

Arbovirus Infections; SARS-CoV Infection

Keywords

Patients with arboviral infection compatible signs; Unexplained isolated fever; Neurological infection conditions without any identified etiology; Arbovirus; Arboviral like infectious disease

Outcome Measures

Primary Outcomes (1)

• Seroprevalence

  Detection of antibodies targeting specific antigens of newly identified arboviruses

  1 day

Secondary Outcomes (1)

• Molecular detection

  1 day

Eligibility Criteria

• Age: Up to 80 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

* Patients admitted at the Monpellier University Hospital for any infectious syndrome compatible with an arboviral infection * Healthy volunteers for seroprevalence investigation

You may qualify if:

• \- Patients admitted at the Monpellier University Hospital for any infectious syndrome compatible with an arboviral infection with samples available

You may not qualify if:

• \- Informed consent non obtain for samples used

Sponsors & Collaborators

• University Hospital, Montpellier: lead
• UMR ASTRE (CIRAD): collaborator
• Institut Pasteur: collaborator
• UMR PCCEI: collaborator

Study Sites (1)

Uh Montpellier

Montpellier, 34295, France

RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

Blood and CSF samples

MeSH Terms

Conditions

Arbovirus Infections; Severe Acute Respiratory Syndrome

Condition Hierarchy (Ancestors)

Vector Borne Diseases; Infections; Virus Diseases; Respiratory Tract Infections; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Respiratory Tract Diseases

Study Officials

• Vincent Foulongne, PhD

  UH MONTPELLIER

  STUDY DIRECTOR

Central Study Contacts

Yannick Simonin, PhD

CONTACT

434359114; yannick.simonin@umontpellier.fr

Vincent Foulongne, PhD

CONTACT

467 330 254; v-foulongne@chu-montpellier.fr

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: July 5, 2021
• First Posted: July 8, 2021
• Study Start: January 1, 2020
• Primary Completion: December 20, 2024
• Study Completion: December 30, 2024
• Last Updated: July 8, 2021

Record last verified: 2021-07

Locations

FR (1)